Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Related Articles by Review for PubMed (Select 20405005)

1.

Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease.

Bangaru ML, Woodliff J, Raff H, Kansra S.

PLoS One. 2010 Apr 13;5(4):e9893. doi: 10.1371/journal.pone.0009893. Erratum in: PLoS One. 2010;5(4). doi:10.1371/annotation/38a101d6-a1f2-4a74-ab63-bc5c61e5f62b.

2.

PPAR-gamma in Cushing's disease.

Heaney AP.

Pituitary. 2004;7(4):265-9. Review.

PMID:
16416039
3.

Somatostatin and somatostatin receptors in Cushing's disease.

Hofland LJ.

Mol Cell Endocrinol. 2008 May 14;286(1-2):199-205. doi: 10.1016/j.mce.2007.10.015. Epub 2007 Nov 22. Review.

PMID:
18221833
4.

The role of somatostatin analogs in Cushing's disease.

van der Hoek J, Lamberts SW, Hofland LJ.

Pituitary. 2004;7(4):257-64. Review.

PMID:
16132202
5.

Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas.

Labeur M, Paez-Pereda M, Arzt E, Stalla GK.

Rev Endocr Metab Disord. 2009 Jun;10(2):103-9. doi: 10.1007/s11154-008-9080-6. Epub 2008 Jul 7. Review.

PMID:
18604646
6.

Pituitary-directed medical therapy with pasireotide for a corticotroph macroadenoma: pituitary volume reduction and literature review.

Shimon I, Rot L, Inbar E.

Pituitary. 2012 Dec;15(4):608-13. doi: 10.1007/s11102-012-0427-3. Review.

PMID:
22918543
7.

Diagnosis and treatment of pituitary adenomas.

Chanson P, Salenave S.

Minerva Endocrinol. 2004 Dec;29(4):241-75. Review.

8.

New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.

Fleseriu M, Petersenn S.

J Neurooncol. 2013 Aug;114(1):1-11. doi: 10.1007/s11060-013-1151-1. Epub 2013 May 15. Review.

9.

Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.

Beauregard C, Dickstein G, Lacroix A.

Treat Endocrinol. 2002;1(2):79-94. Review.

PMID:
15765624
10.

Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature.

van der Klaauw AA, Kienitz T, Strasburger CJ, Smit JW, Romijn JA.

Pituitary. 2009;12(1):57-69. doi: 10.1007/s11102-007-0080-4. Review.

PMID:
18176844
11.

Pituitary tumors: cell type-specific roles for BMP-4.

Labeur M, Páez-Pereda M, Haedo M, Arzt E, Stalla GK.

Mol Cell Endocrinol. 2010 Sep 15;326(1-2):85-8. doi: 10.1016/j.mce.2010.04.006. Epub 2010 Apr 14. Review.

PMID:
20398728
12.

Medical therapy of Cushing's disease: where are we now?

Alexandraki KI, Grossman AB.

Front Horm Res. 2010;38:165-73. doi: 10.1159/000318507. Epub 2010 Jul 5. Review.

PMID:
20616508
13.

Pituitary-targeted medical therapy of Cushing's disease.

Alexandraki KI, Grossman AB.

Expert Opin Investig Drugs. 2008 May;17(5):669-77. doi: 10.1517/13543784.17.5.669 . Review. Erratum in: Expert Opin Investig Drugs. 2008 Jul;17(7):1141.

PMID:
18447593
14.

[Pathology and pathogenesis of pituitary corticotroph adenoma].

Trouillas J.

Neurochirurgie. 2002 May;48(2-3 Pt 2):149-62. Review. French.

PMID:
12058122
15.

Silent corticotroph adenomas.

Karavitaki N, Ansorge O, Wass JA.

Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1314-8. Review.

16.

Medical management of Cushing's disease: what is the future?

Fleseriu M, Petersenn S.

Pituitary. 2012 Sep;15(3):330-41. doi: 10.1007/s11102-012-0397-5. Review.

17.

Medical treatment of Cushing's disease: somatostatin analogues and pasireotide.

Pedroncelli AM.

Neuroendocrinology. 2010;92 Suppl 1:120-4. doi: 10.1159/000314352. Epub 2010 Sep 10. Review.

PMID:
20829632
18.

Pathophysiology of Cushing's disease.

Fehm HL, Voigt KH.

Pathobiol Annu. 1979;9:225-55. Review.

PMID:
225710
19.

Recent developments in drug therapy for Cushing's disease.

van der Pas R, de Herder WW, Hofland LJ, Feelders RA.

Drugs. 2013 Jun;73(9):907-18. doi: 10.1007/s40265-013-0067-6. Review.

PMID:
23737437
20.

Novel medical approaches for the treatment of Cushing's disease.

Heaney AP.

J Endocrinol Invest. 2004 Jun;27(6):591-5. Review. No abstract available.

PMID:
15717660
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk